当前位置:首页 - 行情中心 - 欧康医药(833230) - 财务分析 - 现金流量表

欧康医药

(833230)

  

流通市值:7.08亿  总市值:15.22亿
流通股本:4670.90万   总股本:1.00亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金170,472,258.2274,009,075.82319,235,679.64234,019,482.97
  收到的税费返还1,600,753.061,429,032.257,856,210.514,703,722.85
  收到其他与经营活动有关的现金2,912,458.39274,144.918,966,334.849,010,821.87
  经营活动现金流入小计174,985,469.6775,712,252.97346,058,224.99247,734,027.69
  购买商品、接受劳务支付的现金135,011,363.2668,600,636.41290,733,509.8232,097,518.5
  支付给职工以及为职工支付的现金10,978,754.98,078,759.0723,397,913.2317,596,499.13
  支付的各项税费2,743,230.731,452,866.27,805,991.646,713,310.66
  支付其他与经营活动有关的现金3,479,716.361,165,579.579,672,594.84,056,652.73
  经营活动现金流出小计152,213,065.2579,297,841.25331,610,009.47260,463,981.02
  经营活动产生的现金流量净额22,772,404.42-3,585,588.2814,448,215.52-12,729,953.33
二、投资活动产生的现金流量:
  收回投资收到的现金70,824,474.5733,722,019.27314,866,667.72265,389,395.95
  取得投资收益收到的现金16,650.44,921.43944,982.92770,128.86
  处置固定资产、无形资产和其他长期资产收回的现金净额107,963.72323502,362.52614,546.78
  投资活动现金流入小计70,949,088.6933,727,263.7316,314,013.16266,774,071.59
  购建固定资产、无形资产和其他长期资产支付的现金13,316,754.5115,334,735.0989,675,164.1677,693,201.41
  投资支付的现金66,456,91528,389,330262,954,334202,104,334
  投资活动现金流出小计79,773,669.5143,724,065.09352,629,498.16279,797,535.41
  投资活动产生的现金流量净额-8,824,580.82-9,996,801.39-36,315,485-13,023,463.82
三、筹资活动产生的现金流量:
  吸收投资收到的现金--9,560,8099,560,809
  其中:子公司吸收少数股东投资收到的现金--710,590-
  取得借款收到的现金11,000,000-29,000,00019,000,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计11,000,000-38,560,80928,560,809
  偿还债务支付的现金10,000,000-30,000,00020,000,000
  分配股利、利润或偿付利息支付的现金8,047,313.74159,583.3315,735,637.9215,557,269.58
  支付其他与筹资活动有关的现金152,941.43130,147.66196,593.12178,217.58
  筹资活动现金流出小计18,200,255.17289,730.9945,932,231.0435,735,487.16
  筹资活动产生的现金流量净额-7,200,255.17-289,730.99-7,371,422.04-7,174,678.16
四、汇率变动对现金及现金等价物的影响1,949.4793,141.3528,985.61374,924.95
五、现金及现金等价物净增加额6,749,517.9-13,778,979.36-28,709,705.91-32,553,170.36
  加:期初现金及现金等价物余额22,811,390.722,811,390.751,521,096.6151,521,096.61
  期末现金及现金等价物余额29,560,908.69,032,411.3422,811,390.718,967,926.25
补充资料:
  净利润2,867,815.24-22,115,851.18-
  资产减值准备-34,835.62-2,605,981.05-
  固定资产和投资性房地产折旧9,586,496.51-7,785,469.36-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧9,586,496.51-7,785,469.36-
  无形资产摊销334,803.2-573,861.69-
  处置固定资产、无形资产和其他长期资产的损失3,090.12-885,060.79-
  公允价值变动损失-306,720.1--226,447.55-
  财务费用314,758.06-384,153.3-
  投资损失-43,208.56--944,982.92-
  递延所得税147,551.29--1,743,246.92-
  其中:递延所得税资产减少147,551.29--1,743,246.92-
  存货的减少3,476,576.62--24,736,483.48-
  经营性应收项目的减少30,112,775.47--19,149,973.57-
  经营性应付项目的增加-25,718,967.31-23,784,531.53-
  其他1,833,256.58-3,772,856.88-
  不涉及现金收支的投资和筹资活动金额其他项目787,662.57-773,783.6-
  现金的期末余额29,564,912.17-22,811,390.7-
  减:现金的期初余额22,815,394.27-51,521,096.61-
  现金及现金等价物的净增加额6,749,517.9--28,709,705.91-
公告日期2025-08-272025-04-282025-04-172024-10-30
审计意见(境内)标准无保留意见
TOP↑